Hepatobiliary & Pancreatic Diseases International
搜索
Hepatobiliary & Pancreatic Diseases International
2021年5期
浏览往期
订阅
目录
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study
Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment
Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
Cryptococcosis in patients with liver cirrhosis: Death risk factors and predictive value of prognostic models
Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response
Efficacy and safety of conversion of percutaneous cholecystostomy to endoscopic transpapillary gallbladder stenting in high-risk surgical patients
Pancreas sparing duodenectomy in the treatment of primary duodenal neoplasms and other situations with duodenal involvement
Synergistic effects of anti-angiogenesis and immune checkpoint blockade -a new era of systemic chemotherapy for hepatocellular carcinoma
Bioinformatics: A beacon of hope in identifying molecular target
Intestinal microecology: A crucial strategy for targeted therapy of liver diseases
Application of intraoperative ultrasound in liver surgery
Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment
Combination therapy of dabrafenib plus trametinib in patients with BRAF V600E -mutated biliary tract cancer
Acute hepatitis associated with increased atypical lymphocyte
MEETINGS AND COURSES
EDITORS
INFORMATION FOR READERS
Hepatobiliary&Pancreatic Diseases International